| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |